Gobiquity CEO Michael Brownell breaks down th...
As Global Head of Development Franchise Ophth...
Dorit B. Donoviel, PhD, Deputy Chief Scientis...
At the recent Ophthalmology Innovation Summit...
Jeff George, President & Global Head of Alcon...
Prior to starting Ocular Therapeutix, Amar Sa...
The FDA turned away Alimera Sciences’ bid t...
TearScience CEO Tim Willis discusses the emer...
OIS co-chair Cunningham delivers a high altit...
Eleven Biotherapeutics capitalized on excitin...